Allergan, an AbbVie Company, to Present Data from its Leading Portfolio of Eye Care Treatments at the 2022 American Glaucoma Society (AGS) Annual Meeting

/PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced new data to be presented from Allergan's leading portfolio of eye care treatments at...

Related Keywords

United States ,American ,Michaelr Robinson , ,Instagram ,Linkedin ,Twitter ,American Glaucoma Society ,Drug Administration ,Youtube ,Allergan ,Facebook ,Glaucoma Society ,Annual Meeting ,Month Evaluation ,Gold Standard Pathway Study ,Top Posters Virtual Presentation ,Implant Effects ,Hour Intraocular ,Bimatoprost Implant ,Paper Presentations ,Consumer Indications ,Important Safety ,Prescribing Information ,Gel Stent ,Glaucoma Treatment System ,Glaucoma Treatment ,Allergan Aesthetics ,Abbvie ,